Miyoshi H, Nakaya Y, Saito K, Kishi F, Takakura M, Nomura M
Second Department of Internal Medicine, School of Medicine, University of Tokushima, Japan.
Life Sci. 1995 Mar 3;56(15):PL291-8. doi: 10.1016/0024-3205(95)00079-8.
The aim of this study was to examine the effects of MCI-154, a new positive inotropic agent with vasodilating properties, on the Ca2+-activated K+ channel (KCa channel) of vascular smooth muscle cells. Cultured smooth muscle cells from a porcine coronary artery were studied using the patch-clamp technique. Extracellular application of 100 microM MCI-154 activated the KCa channel in intact cell-attached patch configurations. In excised inside-out patch configurations, application of 100 microM MCI-154 to the cytosolic side activated the KCa channel directly, suggesting that the Ca2+ sensitivity of the KCa channel itself is modulated. Though extracellular application of 100 microM amrinone, a phosphodiesterase inhibitor, activated the KCa channel in the cell-attached patch configurations, application of 100 microM amrinone to the cytosolic side could not activate the KCa channel in inside-out patch configurations. These results indicate that different from amrinone, MCI-154 can modulate Ca2+ sensitivity of the KCa channel in vascular smooth muscle cells.
本研究旨在探讨新型具有血管舒张特性的正性肌力药物MCI - 154对血管平滑肌细胞钙激活钾通道(KCa通道)的影响。采用膜片钳技术研究了猪冠状动脉培养的平滑肌细胞。在完整的细胞贴附式膜片配置中,细胞外施加100微摩尔MCI - 154可激活KCa通道。在切除的内面向外膜片配置中,向胞质侧施加100微摩尔MCI - 154可直接激活KCa通道,这表明KCa通道本身的钙敏感性受到调节。尽管细胞外施加100微摩尔氨力农(一种磷酸二酯酶抑制剂)可在细胞贴附式膜片配置中激活KCa通道,但向胞质侧施加100微摩尔氨力农不能在内面向外膜片配置中激活KCa通道。这些结果表明,与氨力农不同,MCI - 154可调节血管平滑肌细胞中KCa通道的钙敏感性。